Condition: Preterm Labor · Sponsor: Assistance Publique - Hôpitaux de Paris
The purpose of this study is to clinically validate the predictive performance (sensitivity and specificity) of the PrediMAP in-vitro diagnostic medical device to predict delivery within 7 days in the target population of women consulting obstetric emergencies for preterm labor (PTL).
This description comes directly from the study's public registry record.
Jeanne SIBIUDE, MD, PhD · +33 1 47 60 66 11 · jeanne.sibiude@aphp.fr
Karima MESBAHI IHADJADENE, Project Manager · 33 1 58 41 12 11 · karima.mesbahi@aphp.fr
Always discuss trial participation with your own doctor first.
| Louis Mourier Hospital | Colombes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05586334